Search

everythinglearnresearchcommunity

for

Search:↓

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

A person with Turner Syndrome showed severe schizophrenia that didn't respond to treatment and had brain shrinkage.

High levels of prolactin in the blood can be linked to widespread hair loss.

Topiramate may cause reversible hair loss.

A girl with hereditary chorea, likely Huntington's disease, had her condition worsened by lupus.

The letter suggests that psychiatric issues, not a sleep disorder, were likely the cause of a patient's self-inflicted leg ulcers.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Former finasteride users showed higher rates of depression and suicidal thoughts compared to those who never used it.

Herbal remedies can cause adverse effects and need more safety research.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Alopecia is a key indicator of thallium poisoning.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.